Thompson Siegel & Walmsley’s Encompass Health EHC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-47	Closed	-$3K	–	416
2023 Q4	$3K	Sell	47 -160	-77%	-$10.4K	﹤0.01%	502
2023 Q3	$14K	Sell	207 -345	-63%	-$23.7K	﹤0.01%	472
2023 Q2	$37K	Sell	552 -95,080	-99%	-$5.96M	﹤0.01%	433
2023 Q1	$5.17M	Sell	95,632 -50,663	-35%	-$2.95M	0.08%	187
2022 Q4	$8.75M	Buy	+146,295	New	+$7.96M	0.14%	151
2022 Q1	–	Sell	-181	Closed	-$9K	–	648
2021 Q4	$9K	Hold	181	–	–	﹤0.01%	564
2021 Q3	$11K	Hold	181	–	–	﹤0.01%	624
2021 Q2	$11K	Hold	181	–	–	﹤0.01%	641
2021 Q1	$12K	Buy	+181	New	+$11.8K	﹤0.01%	619
2017 Q2	–	Sell	-23	Closed	-$1K	–	845
2017 Q1	$1K	Hold	23	–	–	﹤0.01%	801
2016 Q4	$1K	Buy	+23	New	+$746	﹤0.01%	814
2015 Q1	–	Sell	-3,897	Closed	-$119K	–	700
2014 Q4	$119K	Sell	3,897 -2,891	-43%	-$90.1K	﹤0.01%	420
2014 Q3	$199K	Buy	+6,788	New	+$207K	﹤0.01%	380

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Thompson Siegel & Walmsley's EHC Position: Q1 2024 in Review

Thompson Siegel & Walmsley sold out of Encompass Health (EHC) in Q1 2024, closing a stake of 47 shares — an estimated $3K sold.

Thompson Siegel & Walmsley first reported a position in EHC in Q3 2014 and held it in 13 quarters. The position peaked at $8.75M in Q4 2022. 437 funds tracked by Wall St. Rank hold EHC as of Q1 2024.

Thompson Siegel & Walmsley reported no remaining Encompass Health position as of Q1 2024 after selling out during the quarter.
Thompson Siegel & Walmsley sold 47 Encompass Health shares in Q1 2024, an estimated $3K.
Thompson Siegel & Walmsley first reported a position in Encompass Health in Q3 2014 and held it in 13 quarters.
Thompson Siegel & Walmsley's Encompass Health position peaked at $8.75M in Q4 2022.
437 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2024, filed 9 May 2024.